Expansion-minded Almac stays on task

In pursuit of global domination in clinical trial supplies, Irish contractor Almac has added five depots total in Japan, Thailand, Hong Kong and Taiwan. The additions boost the clinical service unit's depot count to 36, the company says.

It has five more of the audited and GMP-compliant units planned for 2012, and it plans to expand its controlled drug storage network throughout Europe.

Almac has been in expansion model lately. In March, its pharma services unit teamed with an unnamed commercial client to invest in 6,100 square feet of cold storage capacity for antibody-based drugs, bulk substances, trial placebos and filled vials at its facility in Craigavon. And just a year ago, predicting a surge in demand for cold storage, the company announced a 400 percent capacity increase.

- here's the depot story
- see the cold storage article

Suggested Articles

While no shortages of drug supplies have been reported, governments are trying to get a handle on what they can do if they materialize.

Branded drug sales in China could suffer in the short term as marketing activities for new meds are limited to reduce the risk of contagion.

Korean CDMO Samsung Biologics is expanding and China API maker WuXi STA opened a 30,000-square-foot oligonucleotide manufacturing facility.